Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,679 | 18,890 | 30,403 | 84,823 | 20,047 |
| Marketable Securities | 82,840 | 106,077 | 112,743 | 68,564 | 19,298 |
| Receivables | 15,240 | 15,472 | 14,991 | 17,372 | 142,195 |
| Inventories | 6,764 | 6,616 | 7,035 | 6,833 | 6,947 |
| TOTAL | $138,938 | $154,467 | $171,104 | $184,198 | $196,758 |
| Non-Current Assets | |||||
| PPE Net | 2,140 | 2,184 | 2,655 | 2,665 | 2,498 |
| Other Non-Current Assets | 7,996 | 10,677 | 12,759 | 14,735 | 16,737 |
| TOTAL | $10,136 | $12,861 | $15,414 | $17,400 | $19,235 |
| Total Assets | $149,074 | $167,328 | $186,518 | $201,598 | $215,993 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,614 | 3,795 | 3,144 | 1,689 | 5,095 |
| Accrued Expenses | 16,120 | 21,074 | 18,936 | 14,228 | 11,963 |
| Other current liabilities | 11,593 | 21,421 | 10,985 | 16,234 | 5,472 |
| TOTAL | $59,225 | $63,554 | $59,282 | $59,544 | $52,022 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,847 | 19,914 | 19,887 | 19,860 | 19,844 |
| Deferred Revenues | 2,097 | 2,596 | 3,157 | 5,813 | 9,500 |
| Other Non-Current Liabilities | 53,204 | 53,486 | 57,679 | 54,084 | 65,829 |
| TOTAL | $83,051 | $73,400 | $77,566 | $73,944 | $85,673 |
| Total Liabilities | $142,276 | $136,954 | $136,848 | $133,488 | $137,695 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,205 | 17,168 | 17,101 | 17,085 | 17,016 |
| Common Shares | 172 | 172 | 171 | 171 | 170 |
| Retained earnings | -1,351,331 | -1,323,886 | -1,301,245 | -1,280,293 | -1,266,472 |
| Other shareholders' equity | -416 | -102 | 8 | 7 | -1 |
| TOTAL | $6,798 | $30,374 | $49,670 | $68,110 | $78,298 |
| Total Liabilities And Equity | $149,074 | $167,328 | $186,518 | $201,598 | $215,993 |